Bujko K, Suit H D, Springfield D S, Convery K
Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston 02114.
Surg Gynecol Obstet. 1993 Feb;176(2):124-34.
Morbidity from wound healing was retrospectively analyzed in a series of 202 consecutive patients with tumors of the soft tissue of the extremities, torso and head and neck region who were treated with preoperative irradiation and conservative operation at the Massachusetts General Hospital between January 1971 and June 1989. A radiation boost dose was given to 143 patients (71 percent) postoperatively. The overall wound complication rate was 37 percent. One patient died because of necrotizing fasciitis. In 33 instances (16.5 percent), secondary operation was necessary, including six patients (3 percent) who required amputation. The wounds in the remaining 40 patients (20 percent) were treated without operation. Multivariate analyses of the data showed the factors that were significantly associated with wound morbidity: tumor in the lower extremity (p < 0.001), increasing age (p = 0.004) and postoperative boost with interstitial implant (p = 0.016). Accelerated fractionation (BID, two fractions per day) reached borderline statistical significance (p = 0.074). Two other factors showed association with wound morbidity by univariate analysis, but not in multivariate model: high pathologic grade (p = 0.02) and estimated volume of resected specimen > or = 200 milliliters (p = 0.065). Patient gender, intercurrent disease (diabetes or hypertension), obesity, maximal tumor size, primary versus recurrent tumor, duration of bed rest postoperatively, dose of postoperative boost radiation, the use of postoperative boost, the use of adjuvant chemotherapy and year of treatment did not show significant importance for wound morbidity. When the severe wound complications (defined as requiring secondary operation and including the patient who died because of necrotizing fasciitis) were considered, among all analyzed variables, only localization of tumor in the lower extremity as a single factor was significant (p < 0.001). Techniques for managing the wound are considered which are judged likely to contribute to a decrease of the incidence of wound healing delays.
对1971年1月至1989年6月期间在马萨诸塞州总医院接受术前放疗和保守手术治疗的202例连续的四肢、躯干以及头颈部软组织肿瘤患者的伤口愈合相关发病率进行了回顾性分析。143例患者(71%)术后接受了放疗增敏剂量。总体伤口并发症发生率为37%。1例患者因坏死性筋膜炎死亡。33例(16.5%)需要二次手术,其中6例患者(3%)需要截肢。其余40例患者(20%)的伤口未进行手术处理。对数据进行多因素分析显示与伤口发病显著相关的因素:下肢肿瘤(p<0.001)、年龄增加(p = 0.004)以及术后组织间插植放疗增敏(p = 0.016)。加速分割放疗(每天两次,每次两分割)达到了临界统计学意义(p = 0.074)。另外两个因素经单因素分析显示与伤口发病有关,但在多因素模型中并非如此:高病理分级(p = 0.02)以及估计切除标本体积≥200毫升(p = 0.065)。患者性别、并存疾病(糖尿病或高血压)、肥胖、肿瘤最大尺寸、原发性肿瘤与复发性肿瘤、术后卧床时间、术后放疗增敏剂量、放疗增敏的使用、辅助化疗的使用以及治疗年份对伤口发病均未显示出显著影响。当考虑严重伤口并发症(定义为需要二次手术,包括因坏死性筋膜炎死亡的患者)时,在所有分析变量中,仅下肢肿瘤定位这一单一因素具有显著性(p<0.001)。文中还考虑了伤口处理技术,认为这些技术可能有助于降低伤口愈合延迟的发生率。